You just read:

GT Biopharma, Inc. Announces Additional Positive Data From Its Phase 1 Clinical Trial For Myasthenia Gravis and Potential for Acceleration of the Start of Its Phase 2 Trial

News provided by

GT Biopharma Inc

Mar 26, 2018, 07:45 ET